Pharmafile Logo
Pharmafocus logo
Advanced Search

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026
Sales and Marketing Arkin Capital, biotech

Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed to invest in pre-clinical and …

News

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026
Research and Development Bio-Sourcing, Oncology, Zerion Pharma, breast cancer

Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for …

News

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026
Research and Development Biocartis, Mayo Clinic, Oncology, breast cancer

Biocartis has announced a research collaboration with Mayo Clinic in the US, aiming to develop an accelerated sample-to-answer test resulting …

News

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026
Research and Development Blue Earth Therapeutics, Oncology, prostate cancer

Blue Earth Therapeutics, a clinical-stage company specialising in targeted radiotherapeutics, has announced that the first UK patient has received its …

News

Medicus Pharma’s Teverelix shows positive efficacy and safety in premenopausal women

January 13, 2026
Research and Development Endocrinology, Medicus Pharma, Teverelix

Medicus Pharma’s Teverelix has demonstrated long-lasting hormone suppression, as well as a favourable safety profile, in new study data. Teverelix …

News

PSI announces new Osaka office as part of Japanese expansion

January 12, 2026
Sales and Marketing Osaka, PSI

PSI, a global contract research organisation (CRO), has announced the opening of a new office in Osaka as part of …

News

Teva’s Ajovy significantly reduces migraine in children and adolescents

January 12, 2026
Research and Development Neurology, Teva, ajovy, migraine

Teva’s Ajovy (fremanezumab) has demonstrated significant reduction in monthly migraine and headache days in children and adolescents with episodic migraine …

News

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026
Research and Development Gates Foundation, Just – Evotec Biologics

Evotec has announced that its subsidiary, Just – Evotec Biologics, has received a Gates Foundation grant with the goal of …

News

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026
Research and Development FDA, Gastrointestinal tract, Johnson & Johnson

Johnson & Johnson has announced the submission of its Ottava Robotic Surgical System for De Novo classification from the US …

News

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026
Research and Development Psychiatry, ea pharma, schizophrenia

EA Pharma, a subsidiary of Eisai, has announced the initiation of a phase 3 clinical trial of evenamide, a schizophrenia …

News

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026
Chief Business Officer, Eleva

Eleva, a biopharmaceutical company specialising in formerly inaccessible biologics, has announced the appointment of Dr Erich Rajkovic as Chief Business …

Appointment

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026
Manufacturing and Production FDA, MedPharm

MedPharm has announced that the US Food and Drug Administration (FDA) has completed a successful inspection of its topical drug …

News

Mavatar announces research collaboration with Sobi

January 6, 2026
Research and Development Immunology, Mavatar, Rare Diseases, sobi

Mavatar has announced the initiation of a non-clinical research collaboration with Sobi, using Mavatar’s technology to generate data insights into …

News

DemeRx announces completion of alcohol use disorder treatment trial

January 5, 2026
Research and Development DemeRx, alcohol use disorder

DemeRx has announced the successful completion of its phase 1 study of DMX-1001 (oral noribogaine) in the treatment of alcohol …

News

Andera Partners leads financing for asthma treatment company Spiro Medical

January 5, 2026
Sales and Marketing Andera Partners, Asthma & COPD, Spiro Medical

Andera Partners, a private equity firm, has announced its leadership of a $67m series A financing round in Spiro Medical, …

News

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025
Research and Development Bio-Thera, Immunology, Stada

STADA and Bio-Thera’s Gotenfia (golimumab), a biosimilar of Janssen’s Simponi, has received a positive opinion from the European Medicines Agency …

News

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025
Manufacturing and Production Hepatology, Norgine, Vir Biotechnology

Norgine has announced its exclusive licensing agreement with Vir Biotechnology, under which Norgine will commercialise the combination of tobevibart and …

News

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025
Incyclix, board of directors

Incyclix Bio, a cell cycle control company, has announced the appointment of Kimberly Blackwell to its Board of Directors as …

Appointment

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025
General Manager Europe and International, Hansa Biopharma, vice president

Hansa Biopharma, a commercial-stage biopharmaceutical company focusing on rare immunological conditions, has announced the appointment of Max Sakkajja as Vice …

Appointment

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025
Regulatory Affairs, Research and Development Asthma & COPD, GSK

GSK’s Exdensur (depemokimab), a twice-yearly biological medicine, has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026